Bank of New York Mellon
STIM icon

Bank of New York Mellon’s Neuronetics STIM Stock Holding History

Bank of New York Mellon’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-78,605
Closed -$114K – 4426
2026
Q1 		$114K Hold
78,605
– – ﹤0.01% 4088
2025
Q4 		$108K Sell
78,605
-2,716
-3% -$5.68K ﹤0.01% 4099
2025
Q3 		$222K Buy
81,321
+1,315
+2% +$4.67K ﹤0.01% 3975
2025
Q2 		$279K Buy
+80,006
New +$316K ﹤0.01% 3837
2024
Q3 		– Sell
-18,163
Closed -$32.7K – 4164
2024
Q2 		$32.7K Sell
18,163
-30,000
-62% -$86.5K ﹤0.01% 4072
2024
Q1 		$229K Sell
48,163
-11,083
-19% -$39K ﹤0.01% 3894
2023
Q4 		$172K Sell
59,246
-793
-1% -$1.25K ﹤0.01% 3992
2023
Q3 		$81.1K Sell
60,039
-1,295
-2% -$2.27K ﹤0.01% 4114
2023
Q2 		$132K Sell
61,334
-346
-0.6% -$839 ﹤0.01% 4056
2023
Q1 		$179K Hold
61,680
– – ﹤0.01% 3952
2022
Q4 		$424K Sell
61,680
-382
-0.6% -$1.8K ﹤0.01% 3628
2022
Q3 		$197K Hold
62,062
– – ﹤0.01% 4024
2022
Q2 		$199K Sell
62,062
-57,973
-48% -$168K ﹤0.01% 4059
2022
Q1 		$363K Buy
120,035
+172
+0.1% +$581 ﹤0.01% 3902
2021
Q4 		$534K Buy
119,863
+1,366
+1% +$6.69K ﹤0.01% 3773
2021
Q3 		$777K Buy
118,497
+10,966
+10% +$105K ﹤0.01% 3549
2021
Q2 		$1.72M Buy
107,531
+41,664
+63% +$576K ﹤0.01% 3095
2021
Q1 		$815K Sell
65,867
-10,407
-14% -$160K ﹤0.01% 3447
2020
Q4 		$847K Buy
76,274
+9,505
+14% +$71.4K ﹤0.01% 3348
2020
Q3 		$324K Hold
66,769
– – ﹤0.01% 3698
2020
Q2 		$129K Buy
66,769
+19,233
+40% +$39.4K ﹤0.01% 3880
2020
Q1 		$90K Buy
47,536
+16,587
+54% +$51.9K ﹤0.01% 3876
2019
Q4 		$140K Buy
30,949
+780
+3% +$4.85K ﹤0.01% 3979
2019
Q3 		$250K Sell
30,169
-1,337
-4% -$14.6K ﹤0.01% 3843
2019
Q2 		$394K Buy
31,506
+1,270
+4% +$17.9K ﹤0.01% 3714
2019
Q1 		$461K Buy
30,236
+11,160
+59% +$185K ﹤0.01% 3596
2018
Q4 		$370K Buy
19,076
+4,458
+30% +$97.8K ﹤0.01% 3628
2018
Q3 		$468K Buy
+14,618
New +$444K ﹤0.01% 3685

Other funds holding STIM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
DJYG
David J. Yvars Group University Park, Florida $212M AUM 33.06% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
FCG
Fielder Capital Group Nashville, Tennessee $462M AUM 37.71% 1-Year Est. Return
MMA
Miracle Mile Advisors Los Angeles, California $8.53B AUM 21.43% 1-Year Est. Return

Bank of New York Mellon's STIM Position: Q2 2026 in Review

Bank of New York Mellon sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 78,605 shares — an estimated $114K sold.

Bank of New York Mellon first reported a position in STIM in Q3 2018 and held it in 28 quarters. The position peaked at $1.72M in Q2 2021. 24 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Bank of New York Mellon reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
  • Bank of New York Mellon sold 78,605 Neuronetics shares in Q2 2026, an estimated $114K.
  • Bank of New York Mellon first reported a position in Neuronetics in Q3 2018 and held it in 28 quarters.
  • Bank of New York Mellon's Neuronetics position peaked at $1.72M in Q2 2021.
  • 24 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.